Association of COVID-19 infection and the risk of new incident diabetes: a systematic review and meta-analysis
Authors:
Open Access
- 26 August 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1429848
Abstract
Background: As the world population recovers from the COVID-19 infection, a series of acute sequelae emerge including new incident diabetes. However, the association between COVID-19 infection and new incident diabetes is not fully understood. We purpose to determine the risk of new incident diabetes after COVID-19 infection.Methods: PubMed, Embase, and Cochrane Library were used as databases to search for cohort studies published from database inception to February 4, 2024. Two reviewers independently conducted the study screening, data extraction, and risk of bias assessment. A random-effects model was adopted to pool the hazard ratio (HR) with corresponding 95% confidence intervals (CI). Subgroup analysis was conducted to explore the potential influencing factors.Results: A total of 20 cohort studies with over 60 million individuals were included. The pooling analysis illustrates the association between COVID-19 infection and an increased risk of new incident diabetes (HR = 1.46; 95% CI: 1.38-1.55). In subgroup analysis, the risk of type 1 diabetes was HR=1.44 (95% CI: 1.13-1.82), and type 2 diabetes was HR=1.47 (95% CI: 1.36-1.59). A slightly higher risk of diabetes was found in males (HR=1.37; 95% CI: 1.30-1.45) than in females (HR=1.29; 95% CI: 1.22-1.365). The risk of incident diabetes is associated with hospitalization: non-hospitalized patients have an HR of 1.16 (95% CI: 1.07-1.26), normal hospitalized patients have an HR of 2.15 (95% CI: 1.33-3.49), and patients receiving intensive care have the highest HR of 2.88 (95% CI: 1.73-4.79).Conclusions: COVID-19 infection is associated with an elevated risk of new incident diabetes. Patients ever infected with COVID-19 should be recognized as a high-risk population with diabetes.Systematic review registration: https://www.crd.york.ac.uk/prospero, identifier CRD42024522050.Keywords
This publication has 61 references indexed in Scilit:
- Association of COVID-19 Infection With Incident DiabetesJAMA Network Open, 2023
- Association of COVID-19 Vaccination With Risk for Incident Diabetes After COVID-19 InfectionJAMA Network Open, 2023
- Association of SARS-CoV-2 Infection With New-Onset Type 1 Diabetes Among Pediatric Patients From 2020 to 2021JAMA Network Open, 2022
- Bidirectional causal associations between type 2 diabetes and COVID‐19Journal of Medical Virology, 2022
- Incidence of newly diagnosed diabetes after Covid-19Diabetologia, 2022
- Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severityBiomedicine & Pharmacotherapy, 2021
- COVID-19 y diabetes mellitus: una relación bidireccionalClínica e Investigación en Arteriosclerosis, 2021
- Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19Cell Metabolism, 2020
- ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 InfectionClinical Gastroenterology and Hepatology, 2020
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetesActa Diabetologica, 2009